GCM
CVS icon

Gibraltar Capital Management’s CVS Health CVS Stock Holding History

Gibraltar Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-139,592
Closed -$8.78M – 56
2024
Q3 		$8.78M Buy
139,592
+2,845
+2% +$166K 3.94% 11
2024
Q2 		$8.08M Buy
136,747
+1,928
+1% +$121K 3.65% 10
2024
Q1 		$10.8M Sell
134,819
-19,976
-13% -$1.53M 5.01% 6
2023
Q4 		$12.2M Sell
154,795
-7,882
-5% -$561K 5.21% 2
2023
Q3 		$11.4M Buy
162,677
+30,341
+23% +$2.15M 5.04% 3
2023
Q2 		$9.15M Buy
132,336
+26,904
+26% +$1.91M 4.05% 8
2023
Q1 		$7.83M Buy
105,432
+8,017
+8% +$672K 3.66% 9
2022
Q4 		$9.08M Buy
97,415
+1,253
+1% +$121K 4.3% 4
2022
Q3 		$9.17M Buy
96,162
+2,459
+3% +$243K 4.7% 5
2022
Q2 		$8.68M Sell
93,703
-3,438
-4% -$336K 4.22% 4
2022
Q1 		$9.83M Sell
97,141
-6,187
-6% -$650K 4.09% 5
2021
Q4 		$10.7M Sell
103,328
-4,562
-4% -$422K 4.83% 3
2021
Q3 		$9.16M Buy
107,890
+272
+0.3% +$22.8K 4.65% 4
2021
Q2 		$8.63M Buy
107,618
+6,146
+6% +$503K 4.31% 4
2021
Q1 		$7.54M Buy
101,472
+21,261
+27% +$1.55M 3.88% 4
2020
Q4 		$5.48M Buy
80,211
+4,094
+5% +$266K 3.26% 8
2020
Q3 		$4.45M Buy
76,117
+3,028
+4% +$188K 3.1% 11
2020
Q2 		$4.75M Sell
73,089
-343
-0.5% -$21.6K 3.49% 10
2020
Q1 		$4.36M Buy
73,432
+2,975
+4% +$199K 3.1% 10
2019
Q4 		$5.23M Buy
70,457
+3,411
+5% +$240K 3.14% 11
2019
Q3 		$4.23M Sell
67,046
-3,646
-5% -$216K 3.19% 11
2019
Q2 		$3.85M Buy
70,692
+8,548
+14% +$460K 3.97% 10
2019
Q1 		$3.35M Buy
62,144
+4,454
+8% +$275K 3.37% 13
2018
Q4 		$3.78M Buy
+57,690
New +$4.31M 4% 12

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gibraltar Capital Management's CVS Position: Q4 2024 in Review

Gibraltar Capital Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 139,592 shares — an estimated $8.78M sold.

Gibraltar Capital Management first reported a position in CVS in Q4 2018 and held it in 24 quarters. The position peaked at $12.2M in Q4 2023. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Gibraltar Capital Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Gibraltar Capital Management sold 139,592 CVS Health shares in Q4 2024, an estimated $8.78M.
  • Gibraltar Capital Management first reported a position in CVS Health in Q4 2018 and held it in 24 quarters.
  • Gibraltar Capital Management's CVS Health position peaked at $12.2M in Q4 2023.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Gibraltar Capital Management's 13F filing for Q4 2024, filed 5 Feb 2025.